Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 10, 1996, Pages 1654-1663

  Bengtsson, Ders ^a,c   Blomberg, Jonas ^a   Nived, Ola ^a   Pipkorn, Rüdiger ^b   Toth, Lajos ^a   Sturfelt, Gunnar ^a  

^a LUND UNIVERSITY   (Sweden)

^b Replico Medical AB   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMINOACID;

ANTIBODY PRODUCTION; ANTIBODY RESPONSE; APOPTOSIS; CROSS REACTION; DISEASE ACTIVITY; HUMAN; HUMAN CELL; IMMUNOASSAY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RETROPOSON; RETROVIRUS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 10144227098     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780391007     Document Type: Review

References (53)

1. Banki OC, Maceda J, Hurley E, Ablonczy E, Mattson DH, Szegedy L, Hung C, Perl A: Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-a protein: a possible auto-antigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci U S A 89:1939-1943, 1992
2. Brookes SM, Pandolfino YA, Mitchell TJ, Venables PJW, Shattles WG, Clark DA, Entwistle A, Maini RN: The immune response to and expression of cross-reactive retroviral gag sequences in autoimmune disease. Br J Rheumatol 31:735-742, 1992
3. Blomberg J, Nived O, Pipkorn R, Bengtsson A, Erlinge D, Sturfelt G: Increased antiretroviral antibody reactivity in sera from a defined population of patients with systemic lupus erythematosus: correlation with autoantibodies and clinical manifestations. Arthritis Rheum 37:57-66, 1994
4. Garry RF, Fermin CD, Hart DJ, Alexander SS, Donehower LA, Luo-Zhang H: Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 250:1127-1129, 1990
5. Garry RF, Luo H, Fermin CD, Alexander SS: High incidence of seroreactivity to human intracisternal A-type retroviral particle type I in patients with systemic lupus erythematosus (abstract). AIDS Res Hum Retroviruses 10 (suppl 3): 100, 1994
6. Brendel V, Dohlman J, Blaisdell BE, Karlin S: Very long charged runs in systemic lupus erythematosus-associated autoantigens. Proc Natl Acad Sci U S A 88:1536-1540, 1991
7. Jonsson H, Nived O, Sturfelt G: Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 68:141-150, 1989
8. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
9. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
10. Sturfelt G, Nived O, Norberg R, Thorstensson R, Krook K: Anticardiolipin antibodies in patients with systemic lupus erythematosus. Arthritis Rheum 30:382-388, 1987
11. Galli M, Comfurius P, Maasen C, de Baets PJC, van Breda-Vriesman BT, Barbui T, Zwaal RFA, Bevers EM: Anticardiolipin antibodies (ACA) directed to plasma protein cofactor. Lancet 335:1544-1547, 1990
12. Aarden CA, de Groot ER, Feldkamp TEW: Crithidia luciliae, a simple substrate for the determination of anti ds-DNA with immunofluorescence technique. Ann N Y Acad Sci 254:505-515, 1975
13. Tan EM, Kunkel HG: Characteristics of soluble nuclear antigen precipitating with sera from patients with systemic lupus erythematosus. J Immunol 96:464-471, 1966
14. Mårtensson U, Sjöholm AG, Sturfelt G, Truedsson L, Laurell AB: Western blot analysis of human IgG reactive with the collagenous portion of C1q: evidence of distinct binding specificities. Scand J Immunol 35:735-744, 1992
15. Emlen W, Jarusiripipat P, Burdick G: A new ELISA for the detection of double stranded DNA antibodies. J Immunol Methods 132:91-101, 1990
16. Lindeskog M, Blomberg J, Medstrand P: Sequence variation of human endogenous ERV-9-related elements in an env region corresponding to an immunosuppressive peptide: transcription in normal and neoplastic cells. J Virol 67:1122-1126, 1993
17. Seiki M, Hattori S, Hirayama Y, Yoshida M: Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci USA 80:3618-3622, 1983
18. Chen ISY, McLaughlin J, Gasson JC, Clarc SC, Golde DW: Molecular characterization of genome of a novel human T-cell leukemia virus. Nature 305:502-505, 1983
19. Perl A, Rosenblatt JD, Chen ISY, DiVincenzo JP, Bever R, Poiesz BJ, Abraham GN: Detection and cloning of new HTLV-related dogenous sequences in man. Nucleic Acids Res 12:6841-6854, 1989
20. Ono M, Yasunaga T, Miyata T, Ushikubo H: Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumour virus genome. J Virol 60:589-598, 1986
21. Wilkinson DA, Mager DL, Leong JAC: Endogenous human retroviruses. In, The Retroviridae. Vol. 3. Edited by JA Levy. New York, Plenum Press, 1994
22. Medstrand P, Lindeskog M, Blomberg J: Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol 73:2463-2466, 1992
23. Goodchild NL, Wilkinson DA, Mager DL: Recent evolutionary expansion of a subfamily of RTVL-H human endogenous retrovirus-like elements. Virology 196:778-788, 1993
24. Hirose Y, Takamatsu M, Harada F: Presence of env genes in members of the RTVL-H family of human endogenous retrovirus-like elements. Virology 192:52-61, 1993
25. LaMantia G, Maglione D, Pengue Am Di Cristofano A, Simeone A, Lanfrancone L, Lania L: Identification and characterization of novel human endogenous retroviral sequences preferentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res 19:1513-1520, 1991
26. Blomberg J, Robert-Guroff M, Blattner WA, Pipkorn R: Type-and group-specific continuous antigenic determinants of HTLV: use of synthetic peptides for serotyping of HTLV-I and -II infection. J Acquir Immune Defic Syndr Hum Retrovirol 5:294-302, 1992
27. Klasse PJ, Pipkorn R, Blomberg J: Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc Natl Acad Sci U S A 85:5225-5229, 1988
28. Tam JP: Synthetic peptide design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA 85:5409-5413, 1988
29. Blomberg J, Nilsson I, Andersson M: Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J Clin Microbiol 17:1081-1091, 1983
30. Perl A, Colombo E, Dai H, Agarwal R, Mark KA, Banki K, Poiesz BJ, Phillips PE, Hoch SA, Reveille JD, Arnett FC: Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 38:1660-1671, 1995
31. Phillips PE, Johnston SL, Runge LA, Moore JL, Poiesz BJ: High IgM antibody to human T-lymphotropic virus type I in systemic lupus erythematosus. J Clin Immunol 6:234-241, 1986
32. Olsen RG, Tarr MJ, Mathes LE, Whisler R, Du Plessis D, Schulz EJ, Balkeslee JR: Serological and virological evidence of human T-lymphotropic virus in systemic lupus erythematosus. Med Microbiol Immunol (Berl) 176:53-64, 1987
33. Boumpas DT, Popovic M, Mann DL, Balow JE, Tsokos GC: Type C retrovirus of the human T cell leukemia family are not evident in patients with systemic lupus erythematosus. Arthritis Rheum 29:185-188, 1986
34. Pelton BK, North M, Palmer RG, Hylon W, Smith-Burchnell C, Sinclair AL, Malkovsky M, Dalgleish AG, Denman AM: A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 47:206-209, 1988
35. Leib-Mösch C, Brack-Werner R, Werner T, Bachmann M, Faff O, Erfle V, Hehlmann R: Endogenous retroviral elements in human DNA. Cancer Res 50:5636-5642, 1990
36. Larsson E, Kato N, Cohen M: Human endogenous proviruses. Curr Top Microbiol Immunol 148:115-132, 1989
37. Rabson AB, Steele PE, Garon CF, Martin MA: mRNA transcripts related to full-length endogenous retroviral DNA in human cells. Nature 306:604-607, 1983
38. Kato N, Pfeiffer-Ohlsson S, Kato M, Larsson E, Rydnert J, Ohlsson R, Cohen M: Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol 61:2182-2191, 1987
39. Wilkinson DA, Freeman JD, Goodchild NL, Kelleher CA, Mager DL: Autonomous expression of RTVL-H endogenous retrovirus-like elements in human cells. J Virol 64:2157-2167, 1990
40. Strand M, August JT: Type-C RNA virus gene expression in human tissue. J Virol 14:1584-1596, 1974
41. Larsson E, Nilsson BO, Sundström P, Widehn S: Morphological and microbiological signs of endogenous C-virus in human oocytes. Int J Cancer 28:551-557, 1981
42. Jerabek LB, Mellors RC, Elkon KB, Mellors JW: Detection and immunochemical characterization of a primate type C retrovirus-related p30 protein in normal human placentas. Proc Natl Acad Sci U S A 81:6501-6505, 1984
43. Jacquemin PC, Strijckmans P, Thiry L: Study of the expression of a glycoprotein of retroviral origin in the plasma of patients with hematologic disorders and in the plasma of normal individuals. Blood 64:832-841, 1984
44. Jacquemin PC, Strijckmans P: Detection of a retrovirus-related glycoprotein in immune complexes from patients with hematopoietic disorders. Int J Cancer 36:535-539, 1985
45. Stephenson JR, Aaronson SA: Endogenous C-type viral expression in primates. Nature 266:469-472, 1977
46. Nowinski RC, Kachler SL: Antibody to leukemia viruses: widespread occurrence in inbred mice. Science 185:869-871, 1974
47. Oldstone MB, del Villano BC, Dixon FJ: Autologous immune response to the major oncornavirus polypeptides in unmanipulated AKR/J mice. J Virol 18:176-181, 1976
48. Charman HP, Kim N, White M, Marquardt H, Gilden RV, Kawakami T: Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates. J Natl Cancer Inst 55:1419-1424, 1975
49. Charman HP, Gardner MB, McAllister RM, Kim N, Gilden RV: Humoral immune responses of cats to mammalian type-C virus p30s. Int J Cancer 17:98-108, 1976
50. Wallace DJ, Hahn BH: Dubois' Lupus Erythematosus. Fourth edition. Philadelphia, Lea and Febiger, 1993
51. Mellors RC, Shirai T, Aoki T, Huebner RJ, Krawczynski K: Wild type Gross leukemia virus and the pathogenesis of the glomerulonephritis of New Zealand mice. J Exp Med 133:113-132, 1971
52. Wu J, Zhou T, He J, Mountz JD: Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med 178:461-468, 1993
53. Blomberg J, Vincic E, Jönsson C, Medstrand P. Pipkorn R: Identification of regions of HIV-1 p24 reactive sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides. AIDS Res Hum Retroviruses 6:1363-1372, 1989